Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)

SEK 3.35

(-0.3%)

Inventory Summary of Newbury Pharmaceuticals AB (publ)

  • Newbury Pharmaceuticals AB (publ)'s latest annual inventory in 2024 was 4.99 Million SEK , up 137.29% from previous year.
  • Newbury Pharmaceuticals AB (publ)'s latest quarterly inventory in 2024 Q4 was 4.99 Million SEK , down -21.29% from previous quarter.
  • Newbury Pharmaceuticals AB (publ) reported annual inventory of 2.1 Million SEK in 2023, up 18.66% from previous year.
  • Newbury Pharmaceuticals AB (publ) reported annual inventory of 1.77 Million SEK in 2022, down 0.0% from previous year.
  • Newbury Pharmaceuticals AB (publ) reported quarterly inventory of 6.34 Million SEK for 2024 Q3, down -1.73% from previous quarter.
  • Newbury Pharmaceuticals AB (publ) reported quarterly inventory of 6.45 Million SEK for 2024 Q2, up 19.57% from previous quarter.

Annual Inventory Chart of Newbury Pharmaceuticals AB (publ) (2024 - 2021)

Historical Annual Inventory of Newbury Pharmaceuticals AB (publ) (2024 - 2021)

Year Inventory Inventory Growth
2024 4.99 Million SEK 137.29%
2023 2.1 Million SEK 18.66%
2022 1.77 Million SEK 0.0%
2021 - SEK 0.0%

Peer Inventory Comparison of Newbury Pharmaceuticals AB (publ)

Name Inventory Inventory Difference
AcuCort AB -1.09 Million SEK 554.504%
AlzeCure Pharma AB (publ) -2508.00 SEK 199262.679%
BioGaia AB (publ) 181.2 Million SEK 97.243%
Enzymatica AB (publ) 11.49 Million SEK 56.561%
Enorama Pharma AB (publ) 4.29 Million SEK -16.379%
Gabather AB (publ) -1772.00 SEK 281984.876%
Klaria Pharma Holding AB (publ.) - SEK -Infinity%
Moberg Pharma AB (publ) 7.11 Million SEK 29.796%
Nanexa AB (publ) 1.91 Million SEK -161.381%
ODI Pharma AB - SEK -Infinity%
Orexo AB (publ) 42.4 Million SEK 88.219%
Probi AB (publ) 116.7 Million SEK 95.72%
Swedencare AB (publ) 398.1 Million SEK 98.745%
Swedish Orphan Biovitrum AB (publ) 3.87 Billion SEK 99.871%
Toleranzia AB -1.34 Million SEK 472.761%
Vivesto AB - SEK -Infinity%